ArticleBlood advances2025

Safety and efficacy of BCMA-directed chimeric antigen receptor T-cell therapy for the treatment of plasma cell leukemia.

Gliceida M Galarza Fortuna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.